Personalis Inc (PSNL)

$10.75 -1.35 (-11.16%)
Market Cap 1.13B
Revenue (ttm) 69.65M
Net Income (ttm) -81.27M
EPS (ttm) N/A
PE Ratio 0.00
Forward PE N/A
Profit Margin -116.68%
Debt to Equity Ratio 0.00
Volume 4,148,700
Avg Vol 2,386,904
Day's Range N/A - N/A
Shares Out 104.72M
Stochastic %K 55%
Beta 2.28
Analysts Strong Sell
Price Target $10.86

Company Profile

Personalis, Inc. develops, markets, and sells advanced cancer genomic tests and services in the United States and internationally. The company offers NeXT Personal, a tumor-informed liquid biopsy test for detection of minimal residual disease (MRD), therapy response and recurrence monitoring in solid tumor cancers; and ImmunoID NeXT, a tissue-based service that combines whole exome and whole transcriptome sequencing data with advanced analytics to provide a multi-dimensional view of the tumor an...

Industry: Diagnostics & Research
Sector: Healthcare
Phone: 650 752 1300
Fax: 650 752 1301
Address:
6600 Dumbarton Circle, Fremont, United States
LucienW
LucienW Jun. 5 at 8:15 PM
$PSNL well such a bloody day… this may sound crazy but I think we actually did pretty well today, all things considered.
0 · Reply
WOLFSTREET
WOLFSTREET Jun. 5 at 8:15 PM
If u do not believe CC on $BB (which is not actually possible) - facts are facts, just take a look at $PSNL , too many to cover, u need to do a little work on your part, but just a little, CC does all heavy lifting. :)
0 · Reply
ExNoose
ExNoose Jun. 5 at 7:20 PM
$PSNL
0 · Reply
LukasWo
LukasWo Jun. 5 at 6:44 PM
$PSNL this is scary guys... should I buy back the shares I sold yesterday or wait a bit longer?
2 · Reply
Farorm
Farorm Jun. 5 at 6:39 PM
$PSNL no worries, better weeks ahead of us!
0 · Reply
LordBrypto
LordBrypto Jun. 5 at 1:08 PM
$PSNL CEO sold 100k shares
2 · Reply
GGator
GGator Jun. 5 at 11:55 AM
$PSNL a lot of activity here lately!
0 · Reply
arribaStocktrading
arribaStocktrading Jun. 5 at 10:46 AM
$PSNL On this day in history: The geniuses who invented "Sell in May, Walk Away" were completely blindsided by Personalis.
0 · Reply
truehealthvalue
truehealthvalue Jun. 5 at 9:59 AM
$PSNL I would look at $ELTX, About to take off, it will be worth billions in a short time
0 · Reply
truehealthvalue
truehealthvalue Jun. 5 at 9:58 AM
$PSNL
0 · Reply
Latest News on PSNL
Personalis secures fourth Medicare coverage decision for NeXT Personal

2026-05-20T10:10:56.000Z - 17 days ago

Personalis secures fourth Medicare coverage decision for NeXT Personal

Personalis announces that CMS program expanded coverage for NeXT

2026-05-13T10:27:16.000Z - 24 days ago

Personalis announces that CMS program expanded coverage for NeXT

Personalis Transcript: AGM 2026

May 12, 2026, 12:00 PM EDT - 25 days ago

Personalis Transcript: AGM 2026

Personalis price target lowered to $9 from $10 at Morgan Stanley

2026-05-12T15:08:02.000Z - 25 days ago

Personalis price target lowered to $9 from $10 at Morgan Stanley

Personalis price target lowered to $11 from $13 at BTIG

2026-05-11T12:19:55.000Z - 26 days ago

Personalis price target lowered to $11 from $13 at BTIG

Personalis files automatic mixed securities shelf

2026-05-07T22:45:48.000Z - 4 weeks ago

Personalis files automatic mixed securities shelf

Personalis reports Q1 EPS (29c), consensus (27c)

2026-05-07T21:26:54.000Z - 4 weeks ago

Personalis reports Q1 EPS (29c), consensus (27c)

Personalis affirms FY26 revenue view of $78M-$80M, consensus $78.8M

2026-05-07T21:25:28.000Z - 4 weeks ago

Personalis affirms FY26 revenue view of $78M-$80M, consensus $78.8M

Personalis Earnings Call Transcript: Q1 2026

May 7, 2026, 5:00 PM EDT - 4 weeks ago

Personalis Earnings Call Transcript: Q1 2026

Personalis Earnings release: Q1 2026

May 7, 2026, 5:00 PM EDT - 4 weeks ago

Personalis Earnings release: Q1 2026

Personalis Quarterly report: Q1 2026

May 7, 2026, 5:00 PM EDT - 4 weeks ago

Personalis Quarterly report: Q1 2026

Personalis management to meet virtually with Lake Street

2026-05-05T15:25:38.000Z - 4 weeks ago

Personalis management to meet virtually with Lake Street

Personalis Proxy statement: Proxy filing

Apr 2, 2026, 8:00 AM EDT - 2 months ago

Personalis Proxy statement: Proxy filing

Personalis Proxy statement: Proxy filing

Apr 2, 2026, 8:00 AM EDT - 2 months ago

Personalis Proxy statement: Proxy filing

Personalis names Richard Chen president

2026-03-17T20:15:19.000Z - 2 months ago

Personalis names Richard Chen president

Personalis’ NeXT Personal test shows predictive efficacy in breast cancer

2026-03-12T10:16:13.000Z - 3 months ago

Personalis’ NeXT Personal test shows predictive efficacy in breast cancer

Personalis price target lowered to $10 from $11 at Morgan Stanley

2026-03-05T14:28:06.000Z - 3 months ago

Personalis price target lowered to $10 from $11 at Morgan Stanley

Personalis Earnings Call Transcript: Q4 2025

Feb 26, 2026, 5:00 PM EST - 3 months ago

Personalis Earnings Call Transcript: Q4 2025

Personalis Annual report: Q4 2025

Feb 26, 2026, 5:00 PM EST - 3 months ago

Personalis Annual report: Q4 2025

Personalis Earnings release: Q4 2025

Feb 26, 2026, 5:00 PM EST - 3 months ago

Personalis Earnings release: Q4 2025

Personalis sees FY26 revenue $78M-$80M, consensus $81.7M

2026-02-26T21:47:54.000Z - 3 months ago

Personalis sees FY26 revenue $78M-$80M, consensus $81.7M

Personalis reports Q4 EPS (26c), consensus (28c)

2026-02-26T21:18:27.000Z - 3 months ago

Personalis reports Q4 EPS (26c), consensus (28c)

Personalis’ MRD test receives Medicare coverage in lung cancer surveillance

2026-02-10T11:21:43.000Z - 4 months ago

Personalis’ MRD test receives Medicare coverage in lung cancer surveillance

Personalis announces publication of new study on NeXT Personal

2026-02-02T11:10:08.000Z - 4 months ago

Personalis announces publication of new study on NeXT Personal

Personalis price target raised to $13 from $12 at Guggenheim

2026-01-26T14:41:40.000Z - 4 months ago

Personalis price target raised to $13 from $12 at Guggenheim

Personalis sees FY25 revenue $69M-$70M, consensus $69.96M

2026-01-08T13:26:40.000Z - 5 months ago

Personalis sees FY25 revenue $69M-$70M, consensus $69.96M

Personalis narrows Q4 revenue view to $17M-$18M from $15.7M-$20.7M

2026-01-08T13:20:13.000Z - 5 months ago

Personalis narrows Q4 revenue view to $17M-$18M from $15.7M-$20.7M

LucienW
LucienW Jun. 5 at 8:15 PM
$PSNL well such a bloody day… this may sound crazy but I think we actually did pretty well today, all things considered.
0 · Reply
WOLFSTREET
WOLFSTREET Jun. 5 at 8:15 PM
If u do not believe CC on $BB (which is not actually possible) - facts are facts, just take a look at $PSNL , too many to cover, u need to do a little work on your part, but just a little, CC does all heavy lifting. :)
0 · Reply
ExNoose
ExNoose Jun. 5 at 7:20 PM
$PSNL
0 · Reply
LukasWo
LukasWo Jun. 5 at 6:44 PM
$PSNL this is scary guys... should I buy back the shares I sold yesterday or wait a bit longer?
2 · Reply
Farorm
Farorm Jun. 5 at 6:39 PM
$PSNL no worries, better weeks ahead of us!
0 · Reply
LordBrypto
LordBrypto Jun. 5 at 1:08 PM
$PSNL CEO sold 100k shares
2 · Reply
GGator
GGator Jun. 5 at 11:55 AM
$PSNL a lot of activity here lately!
0 · Reply
arribaStocktrading
arribaStocktrading Jun. 5 at 10:46 AM
$PSNL On this day in history: The geniuses who invented "Sell in May, Walk Away" were completely blindsided by Personalis.
0 · Reply
truehealthvalue
truehealthvalue Jun. 5 at 9:59 AM
$PSNL I would look at $ELTX, About to take off, it will be worth billions in a short time
0 · Reply
truehealthvalue
truehealthvalue Jun. 5 at 9:58 AM
$PSNL
0 · Reply
Spicy_Trade
Spicy_Trade Jun. 5 at 2:23 AM
Personalis, Inc. ( $PSNL ) SpicyTrade - Daily Stock Analysis https://youtu.be/DRrSDdIvV7o?si=VF8qKvtlFf6uUGml
0 · Reply
topstockalerts
topstockalerts Jun. 5 at 12:45 AM
$PSNL the market seems to like this one
0 · Reply
WOLFSTREET
WOLFSTREET Jun. 4 at 10:29 PM
$PSNL What's not to like about CC, 155% in 3 quarters. I like it!
0 · Reply
BioTechNoir
BioTechNoir Jun. 4 at 10:09 PM
$PSNL
0 · Reply
Tejj
Tejj Jun. 4 at 7:47 PM
$PSNL waited quite a whilw for this breakout
0 · Reply
Slowhorses
Slowhorses Jun. 4 at 7:38 PM
$PSNL $ABCL $OSCR Categories are different but overall "HEALTHCARE" is on the rise.
0 · Reply
arribaStocktrading
arribaStocktrading Jun. 4 at 7:14 PM
$PSNL
1 · Reply
MD109
MD109 Jun. 4 at 5:42 PM
$PSNL Someone mentioned private payer coverage which is important to consider. This is another future catalyst that could lead to a significant positive re-rating event. Currently, there is broad private payer MRD coverage for hematologic malignancies. The major players in the solid tumor MRD space have multiple ongoing studies in order to demonstrate clinical utility - specifically do MRD results change management and result in increased overall survivial. Also, the question of the healthcare economic benefits of MRD is being looked at carefully. There is a great organization called Bloodpac which is helping drive this effort.  Private payers typically require FDA clearance or solid clinical utility evidence before establishing broad coverage policies. The LDT status of most solid tumor MRD tests is the main reason commercial coverage remains fragmented. I think private payer MRD coverage for solid tumors will make very big strides within the next 12 to 24 months - led by CRC.
1 · Reply
inmarketswetrust
inmarketswetrust Jun. 4 at 3:53 PM
$PSNL all the testing names are doing well
0 · Reply
BeeDecay
BeeDecay Jun. 4 at 3:13 PM
$PSNL Not too shabby. Biotech ripping higher today after some week days.
0 · Reply
LordBrypto
LordBrypto Jun. 4 at 2:59 PM
$PSNL what is cooking ?
0 · Reply
MD109
MD109 Jun. 4 at 2:57 PM
$PSNL Still first inning.. Own - don’t trade.
0 · Reply